Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regions Financial C Pref | RF-C | Nov 22, 2024 | 24.68 | +0.28 |
Regions Financial E Pref | RF-E | Nov 22, 2024 | 19.43 | +0.41 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 22, 2024 | 25.95 | +0.15 |
Regis | RGS | Nov 22, 2024 | 22.50 | +5.09 |
Regulus Therapeutics | RGLS | Nov 22, 2024 | 1.47 | +5.00 |
Reinsurance Group of America | RGA | Nov 22, 2024 | 230.70 | +0.67 |
REIT Index ETF Vanguard | VNQ | Nov 22, 2024 | 96.24 | +0.75 |
Reitar Logtech | RITR | Nov 22, 2024 | 4.91 | 0.00 |
Rekor Systems | REKR | Nov 22, 2024 | 0.96 | -0.75 |
Relay Therapeutics | RLAY | Nov 22, 2024 | 4.75 | +2.37 |
Reliance | RS | Nov 22, 2024 | 319.27 | +0.90 |
Reliance Global | RELI | Nov 22, 2024 | 1.29 | -0.77 |
Relmada Therapeutics | RLMD | Nov 22, 2024 | 2.80 | +1.82 |
RELX ADR | RELX | Nov 22, 2024 | 46.75 | +2.16 |
Remitly Global | RELY | Nov 22, 2024 | 21.04 | +1.74 |
Renaissance Ipo ETF | IPO | Nov 22, 2024 | 46.12 | +1.23 |
RenaissanceRe | RNR | Nov 22, 2024 | 271.90 | +2.74 |
RenaissanceRe G Pref | RNR-G | Nov 22, 2024 | 18.15 | +0.33 |
RenaissanceRe Holding F Pref | RNR-F | Nov 22, 2024 | 24.48 | +0.20 |
Renalytix ADR | RNLX | Nov 22, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 22, 2024 | 37.90 | +1.61 |
ReNew Energy Global A Shares | RNW | Nov 22, 2024 | 5.89 | +4.62 |
Renn Fund | RCG | Nov 22, 2024 | 2.70 | +13.92 |
Renovaro Biosciences | RENB | Nov 22, 2024 | 0.52 | +3.63 |
RenovoRx | RNXT | Nov 22, 2024 | 1.29 | +6.60 |
Rent The Runway A | RENT | Nov 22, 2024 | 9.60 | -0.83 |
Rentokil Initial ADR | RTO | Nov 22, 2024 | 25.98 | +1.41 |
Repare Therapeutics | RPTX | Nov 22, 2024 | 2.81 | -5.39 |
Repay A | RPAY | Nov 22, 2024 | 8.05 | +0.25 |
Repligen | RGEN | Nov 22, 2024 | 142.58 | +0.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.